One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Smart apps for self-reporting clinical information
LindaHouhamdiabcPierre-EdouardFournierabc
Understanding the changing health of the Iranian people
ElhamAhmadnezhadaMartinMcKeeb
New global WHO postnatal guidance is welcome but misses the long-term perspective
DebraBickaUmaRamcPonnusamySaravananbMarleenTemmermande
Reflexivity, Cultural Safety, and improving the health of racially minoritised communities
Dipesh PGopalaChristineDouglassbSarahWongcImranKhanaAmali ULokugamaged
Offline: France and some lessons for a fairer society
RichardHorton
Transgender Ukrainians facing “exacerbated� challenges
EdHolt
Medicare covers new Alzheimer's drug, but there is a catch
SusanJaffe
Picturing health: the burden of leprosy in eastern Indonesia
YoppyPieteraMarlous LGrijsenbc
Should peer reviewers be paid to review academic papers?
Phaik YeongCheahabJanPiaseckic
Synthetic patient data in health care: a widening legal loophole
AnmolAroraaAnanyaAroraa
Advanced endoscopy unit in Gaza: first year of activity
IyadKhamaysiabcAlaaAlshaerdKhaledMatare
Nociplastic pain is functional pain
ConstanzeHausteiner-WiehleabPeterHenningsenb
Nociplastic pain is functional pain – Authors' reply
Steven PCohenabMary-AnnFitzcharlescWinfriedHauserde
Expanding diagnostics for LMICs
StuartGilmouraYuyingLaibPhuong MaiLeaOlukunmi OmobolanleBalogunc
Expanding diagnostics for LMICs – Authors' reply
KennethFlemingaSusanHortonbMichael LWilsonccommissioners of the Lancet Commission on Diagnostics
Transforming the UK's diagnostics agenda after COVID-19
Dimitris KGrammatopoulosabcLawrenceYoungaNeil RAndersonbc
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial
ProfHisashiSajiMDaMorihitoOkadaMDbMasahiroTsuboiMDcRyuNakajimaMDdKenjiSuzukiMDeKeijuAokageMDcTadashiAokiMDfJiroOkamiMDgIchiroYoshinoMDhHiroyukiItoMDiNorihitoOkumuraMDjMasafumiYamaguchiMDkNorihikoIkedaMDlMasashiWakabayashiMScmKenichiNakamuraMDmHaruhikoFukudaMDmShinichiroNakamuraMDoTetsuyaMitsudomiMDp…HisaoAsamuraMDq
Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study
CristinaMenniPhDa*ProfAna MValdesPhDc*LorenzoPolidoriMScdMichelaAntonelliPhDbSatyaPenamakuriMScdAnaNogalMScaPanayiotisLoucaMScaAnnaMayMAdJane CFigueiredoPhDeChristinaHuMAdErikaMolteniPhDbLianeCanasPhDbMarc FÖsterdahlMBBSafMarcModatPhDbCarole HSudrePhDbghBenFoxBScdProfAlexanderHammersPhDbiJonathanWolfMAd…ProfTim DSpectorMDaâ€
Health system performance in Iran: a systematic analysis for the Global Burden of Disease Study 2019
GBD 2019 Iran Collaboratorsâ€
Pyogenic granuloma-like Kaposi's sarcoma
MichaelMegalyMDaNasserBoshraMDa
Acute glomerulonephritis
SanjeevSethiMDaAn SDe VrieseMDcdFernando CFervenzaMDb
Disease-modifying anti-asthmatic drugs
ProfMarekLommatzschMDaProfGuy GBrusselleMDbProfG WalterCanonicaMDcProfDavid JJacksonMDdProfParameswaranNairMDeProfRolandBuhlMDf†ProfJohann ChristianVirchowMDaâ€
